Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.7501
Delayed Data
As of 3:59pm ET
 -0.0291 / -3.73%
Today’s Change
0.73
Today|||52-Week Range
7.10
-74.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues33.9M47.0M48.6M46.4M
 
 
 
 
 
Cost of Goods Sold11.1M13.8M12.0M14.5M
 
 
 
 
 
Depreciation And Amortization18.4M22.3M25.7M28.2M
 
 
 
 
 
 
Operating ExpensesGross Income4.4M10.9M10.8M3.7M
 
 
 
 
 
General Expenses22.0M23.2M30.4M26.7M
 
 
 
 
 
Research And Development994.0K1.5M3.2M2.6M
 
 
 
 
 
Total Operating Expenses51.5M59.3M68.2M69.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.6M-12.4M-19.6M-23.1M
 
 
 
 
 
Extraordinary Credit--8.7M14.1M141.0K
 
 
 
 
Extraordinary Charge-1.3M-22.5M-1.3M-27.8M
 
 
 
 
 
Interest Expense On Debt9.4M9.9M9.7M9.3M
 
 
 
 
 
Other Expenses0.000.000.00-582.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.2M-35.8M-16.4M-60.8M
 
 
 
 
 
Income Taxes-4.6M-3.6M-5.6M-20.9M
 
 
 
 
 
Net Income-23.7M-32.2M-10.7M-81.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS38.5M52.4M61.0M61.1M
 
 
 
 
 
Shares To Calculate EPS Diluted38.5M52.4M61.0M61.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.62-$0.62-$0.18-$1.34
 
 
 
 
 
EPS Diluted-$0.62-$0.62-$0.18-$1.34